FindTrial
Sign In

Administration, Rectal

7 trials

Sponsors

Center for Genetic Engineering and Biotechnology (CIGB), Genetic and Biotechnological Engineering Center (CIGB), of Havana., Roberto Rodriguez Fernandez General Hospital, National Center for Scientific Research (CNIC), National Center for Scientific Research

Conditions

Acute Haemorrhoidal Disease.COVID-19 COVID-19 SARS-CoV2COVID-19 COVID-19 SARS-CoV2Covid 19 COVID-19Hemorrhoidal crisis.Immunoglobulin A Deficiencypelvic inflammatory disease

Phase 1

THERESA
Active, not recruitingRPCEC00000021
Genetic and Biotechnological Engineering Center (CIGB), of Havana.Acute Haemorrhoidal Disease.
Start: 2006-05-21Target: 10Updated: 2026-03-30

Phase 2

THERESA-2 Study
Active, not recruitingRPCEC00000018
Center for Genetic Engineering and Biotechnology (CIGB)Hemorrhoidal crisis.
Start: 2007-10-02Target: 80Updated: 2026-03-30
Ozone-Therapy-Immunoglobulin A deficiency-adults and childrens-Phase II
Active, not recruitingRPCEC00000236
Roberto Rodriguez Fernandez General HospitalImmunoglobulin A Deficiency
Start: 2010-01-18Updated: 2026-03-30
PROCTOKINASE in acute pelvic inflammatory disease
Active, not recruitingRPCEC00000416
Matanzas University of Medical Sciencespelvic inflammatory disease
Start: 2016-06-01Target: 76Updated: 2026-03-30

Phase 3

Rectal ozone therapy in high-risk symptomatic SARS-CoV-2 positive patients
Active, not recruitingRPCEC00000383
National Center for Scientific Research (CNIC)COVID-19 COVID-19 SARS-CoV2
Start: 2021-09-01Target: 292Updated: 2026-03-30

Unknown Phase

Rectal Ozone in the COVID-19 treatment
Active, not recruitingRPCEC00000320
National Center for Scientific Research (CNIC)Covid 19 COVID-19
Start: 2020-06-08Target: 32Updated: 2026-03-30
Observational study of the benefits of rectal ozonotherapy and BIOPLA as complemetary theraphy in convalescent patients with SARS-COV 2
Active, not recruitingRPCEC00000342
National Center for Scientific ResearchCOVID-19 COVID-19 SARS-CoV2
Start: 2020-06-08Target: 40Updated: 2026-03-30